Delivery Order SPE2DE24D0013-SPE2D625F0HWS
- Not listed
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,654.60 firm fixed-price delivery order (Contract No. GXCT/NG-10) by the Defense Logistics Agency's Medical Supply Chain division on May 6, 2025, with an ultimate completion date of May 13, 2025. The contract carries no set-aside designation and will be performed in Sunnyvale, California. This delivery order represents a continuation of Cepheid's ongoing relationship with the federal...
- Cepheid, a molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, received a delivery order award valued at $5,443.58 under contract number XPRSMVP-10 from the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which was not set-aside for any specific business category, was awarded on August 21, 2025, with an ultimate completion date of August 28, 2025. The work will be performed in Sunnyvale, California, and represents...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,760 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025, with an ultimate completion date of August 27, 2025. This contract carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, which enable the company to provide molecular diagnostic...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, has been awarded a delivery order valued at $2,040 under contract XPRS4PLEX-10 by the Medical Supply Chain, a defense-focused federal agency. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California, and represents a continuation of Cepheid's ongoing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $6,544 firm fixed-price delivery order by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 1, 2025. The contract (4569580744 | XPRS4PLEX-10) carries no set-aside designation and represents a discrete purchase order under Cepheid's existing procurement relationship with the federal government. Cepheid specializes in advanced diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,880.04 by the Defense Logistics Agency Medical Supply Chain on October 17, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by October 24, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0HWSDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $49,896.50 on August 6, 2025, under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The delivery order, which bears the contract number 4569009272 and identifier XPRS4PLEX-10, carries an ultimate completion date of August 13, 2025, and involves performance in Sunnyvale, California. This award utilizes no set-aside designation and represents a discrete procurement of diagnostic equipment or reagents consistent with Cepheid's core business of providing molecular diagnostic testing solutions to federal healthcare agencies. This delivery order aligns with Cepheid's established role as a leading supplier of molecular diagnostic systems and associated products to the federal government. The company maintains two significant Indefinite Delivery Vehicle contracts with Veterans Integrated Service Networks valued at approximately $35.3 million combined, which enable ongoing procurement of diagnostic reagents and assays through 2030. The Medical Supply Chain award reflects continued federal reliance on Cepheid's GeneXpert diagnostic systems and related molecular testing capabilities for detecting infectious diseases and clinical conditions across the defense healthcare system. No major subcontractors are identified in this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.9k | 8/6/25 |